Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs
Go back to Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs| Beam Inc. (NASDAQ: BEAM) | Delayed: 24.77 +1.67 (7.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.10 | 52 Week High | $83.60 | |||
| Open | $24.28 | 52 Week Low | $82.96 | |||
| Day High | $25.50 | P/E | 11.06 | |||
| Day Low | $24.05 | EPS | $2.24 | |||
| Volume | 1,771,931 | |||||
| Beam Inc. (NASDAQ: BEAM) | Delayed: 24.77 +1.67 (7.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.10 | 52 Week High | $83.60 | |||
| Open | $24.28 | 52 Week Low | $82.96 | |||
| Day High | $25.50 | P/E | 11.06 | |||
| Day Low | $24.05 | EPS | $2.24 | |||
| Volume | 1,771,931 | |||||
